tirzepatide phase 2 A drug called apitegromab may help to preserve lean body mass during weight loss with tirzepatide, a GLP-1 receptor agonist, according to a clinical trial published in Nature Medicine. The Today, we reported positive Phase

Autonomydependency dynamics may also become relevant

The dependent variables were selected to measure both physiological responses and subjective exertion: Heart rate: Used to assess cardiovascular function during exercise and track changes in heart rate with the different interventions

Check out exciting new research in Annals of Internal Medicine led by PETS associate professor Chintan Dave on the increased risk of sudden vision loss associated with GLP-1 medications

GLP1 medicines carry warnings related to thyroid Ccell tumors in rodent studies

The quality of your results is a direct reflection of the quality of your process

10.1161/ATVBAHA.112.246207 228